Company record
Nipro Renal Soultions USA, Corporation
0 FDA warning letters since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Nipro Renal Soultions USA, Corporation.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Sep 16 | Class II | Nipro Renal Soultions USA, Corporation Device |
MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201 Hemodialysis concentrates contain high endotoxin levels |
| Sep 16 | Class II | Nipro Renal Soultions USA, Corporation Device |
Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X) Hemodialysis concentrates contain high endotoxin levels |
| Sep 16 | Class II | Nipro Renal Soultions USA, Corporation Device |
MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)) Hemodialysis concentrates contain high endotoxin levels |
| Sep 16 | Class II | Nipro Renal Soultions USA, Corporation Device |
Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25 Hemodialysis concentrates contain high endotoxin levels |